A good point to remember is that there is unlikely to be a forewarning to Ann timing and many investors may be caught very short here missing out on any rerate based on OSA, listing and options entitlement. The options are a stroke of genius from IHL to reward loyal shareholders. A double bonus with a lot of newsflow to come.
The OS markets looking better too. The value of IHL compared to peers at current valuations - even just in the psychedelics space, is low. As a recap, dividing IHL shares on issue into the market caps of Mindmed, Compass and Atai comes in at 70, 72 and 95 cents. So for example, if IHL was to be the same market cap as ATAI, its SP would have to be 95 cents.
IHL Price at posting:
43.5¢ Sentiment: Buy Disclosure: Held
